Blinatumomab: A historical perspective
Top Cited Papers
- 1 December 2012
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 136 (3), 334-342
- https://doi.org/10.1016/j.pharmthera.2012.07.013
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced LeukemiaScience Translational Medicine, 2011
- Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiationCurrent Opinion in Immunology, 2011
- Tumor immunosurveillance in human cancersCancer and Metastasis Reviews, 2011
- Rituximab in Indolent LymphomasSeminars in Hematology, 2010
- Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemiaHaematologica, 2009
- Mode of cytotoxic action of T cell-engaging BiTE antibody MT110Immunobiology, 2009
- Tumor Microenvironment and Immune EscapeSurgical Oncology Clinics of North America, 2007
- Immune surveillance of tumorsJCI Insight, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007